| S8588 |
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor)
|
ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).
|
-
Nat Commun, 2025, 16(1):2071
-
Cell Death Dis, 2025, 16(1):650
-
Cell Rep, 2025, 44(7):115947
|
|
| E1147 |
VY-3-135
|
VY-3-135, a potent ACSS2 inhibitor with IC50 of 44 ± 3.85 nM, potently inhibits ACSS2 dependent fatty acid metabolism but has no effect on gene expression in tumors.
|
-
Cancers (Basel), 2024, 16(5)1035
|
|
| E1931 |
AD-5584
|
AD-5584 is a specific inhibitor of human acyl-CoA synthetase short chain family member 2 (ACSS2). It significantly reduces lipid storage, decreases colony formation, and increases cell death in vitro, while also confirming blood-brain barrier (BBB) permeability.
|
|
|
| E1930 |
AD-8007
|
AD-8007 is a selective and brain-penetrant inhibitor of acetyl CoA synthase 2 (ACSS2). This compound significantly reduces lipid storage, cell colony formation, acetyl-CoA levels and cell survival in vitro models, and increases tumor cell death, tumor burden and increases survival in in-vivo models. It exhibits anti-cancer activity.
|
|
|
| E1211 |
MTB-9655
|
MTB-9655 is a novel, potent and selective Acetyl-Coenzyme A Synthetase 2 (ACSS2) inhibitor, which is currently in Phase I clinical investigation on patients with tumors with high levels of ACSS2.
|
|
|